Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Catch Up GLP-1 medications, including Ozempic, Wegovy and Zepbound, are being studied for potential uses beyond diabetes and weight management
This personalized assessment helps determine whether oral tirzepatide aligns with your genetic predisposition for GIP-receptor responsiveness, or whether injectable formulations may deliver superior outcomes based on your unique peptide-pathway profile
PC=Placebo An RCT of nondiabetic patients (N = 1961)1: After 68 weeks, mean weight loss was 15% (15 kg) versus 2% (3 kg) PC
Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, et al
US$ 20.53
US$ 27.59
US$ 27.79
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 22.48
